Business Context and Reporting Period
Company: Achieve Life Sciences, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: March 14, 2019
Reporting Period: Fourth quarter and full year ended December 31, 2018.
This filing serves as a notification that the Company issued a press release on March 14, 2019, announcing its financial results for the periods mentioned above. The press release is included as Exhibit 99.1.
Key Financial Metrics
The provided text is a cover sheet for the Form 8-K and does not contain specific financial data. It references a press release (Exhibit 99.1) for details on revenue, profit, cash flow, margins, debt, and liquidity.
Specific values for revenue, profit, cash flow, margins, debt, and liquidity are not present in the source text.
Material Changes
The filing text does not provide specific details regarding material changes versus prior comparable periods. It only indicates that such results were announced in the referenced press release.
Guidance, Outlook, and Risks
The text does not contain management commentary, guidance, outlook, risks, contingencies, or unusual items. These details are contained within the attached press release (Exhibit 99.1), which is not included in the provided input.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated March 14, 2019) for actual financial figures and operational highlights.
- Verify the specific revenue and net income figures for Q4 and full-year 2018 in the attached press release.
- Check for any forward-looking statements or guidance updates in the press release.
- Confirm the status of the Company's cash position and liquidity as detailed in the full financial report.